O'Kane Kieran (CIK 1828131) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-23). Recent activity: Buy BDSX (1,469 shares), Sell BDSX (535 shares), Buy BDSX (1,600 shares), Sell BDSX (584 shares), Buy BDSX (805 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-23 | BIODESIX INC (BDSX) | Chief Commercial Officer | Buy | 1,469 | $0 |
| 2026-02-23 | BIODESIX INC (BDSX) | Chief Commercial Officer | Sell | 535 | $6,837 |
| 2026-02-11 | BIODESIX INC (BDSX) | Chief Commercial Officer | Buy | 1,600 | $0 |
| 2026-02-11 | BIODESIX INC (BDSX) | Chief Commercial Officer | Sell | 584 | $5,887 |
| 2026-01-20 | BIODESIX INC (BDSX) | Chief Commercial Officer | Buy | 805 | $0 |
| 2026-01-20 | BIODESIX INC (BDSX) | Chief Commercial Officer | Sell | 298 | $2,429 |
| 2025-11-13 | BIODESIX INC (BDSX) | Chief Commercial Officer | Buy | 75 | $0 |
| 2025-11-13 | BIODESIX INC (BDSX) | Chief Commercial Officer | Sell | 25 | $190 |
| 2025-08-14 | BIODESIX INC (BDSX) | Chief Commercial Officer | Buy | 1,489 | $0 |
| 2025-08-14 | BIODESIX INC (BDSX) | Chief Commercial Officer | Sell | 476 | $0 |
| 2025-05-13 | BIODESIX INC (BDSX) | Chief Commercial Officer | Buy | 1,490 | $0 |
| 2025-05-13 | BIODESIX INC (BDSX) | Chief Commercial Officer | Sell | 239 | $0 |
| 2025-05-13 | BIODESIX INC (BDSX) | Chief Commercial Officer | Sell | 238 | $0 |
| 2025-02-12 | BIODESIX INC (BDSX) | Chief Commercial Officer | Buy | 48,118 | $0 |
| 2025-02-12 | BIODESIX INC (BDSX) | Chief Commercial Officer | Sell | 17,527 | $0 |
Source: SEC Form 4 filings · as of 2026-02-23